BIOTIE THERAPIES CORP SPONSORED ADR
BITI
BITI was delisted on the 10th of June, 2016.
19 hedge funds and large institutions have $98.5M invested in BIOTIE THERAPIES CORP SPONSORED ADR in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
80% more capital invested
Capital invested by funds: $54.7M → $98.5M (+$43.8M)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
27% more funds holding
Funds holding: 15 → 19 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.56M |
| 2 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$2.55M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.29M |
| 4 |
GP
GLG Partners
London,
United Kingdom
|
+$1.26M |
| 5 |
GL
GLG LLC
New York
|
+$1.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.86M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.83M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.74M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.78M |
BITI Hedge Fund Activity: Q1 2016 in Review
19 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in BIOTIE THERAPIES CORP SPONSORED ADR (BITI) for Q1 2016, worth a combined $98.5M — up 80% from $54.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BITI positions and 8 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.56M. The largest seller was Fidelity Investments, exiting entirely with an estimated $15.2M sold.
- 19 institutional investors held BIOTIE THERAPIES CORP SPONSORED ADR (BITI) as of Q1 2016, up from 15 in Q4 2015.
- Funds reported $98.5M of BIOTIE THERAPIES CORP SPONSORED ADR stock for Q1 2016, up 80% quarter-over-quarter.
- 12 funds opened new BIOTIE THERAPIES CORP SPONSORED ADR positions in Q1 2016 and 8 closed out, a net change of +4 holders.
- The largest BIOTIE THERAPIES CORP SPONSORED ADR buyer in Q1 2016 was Morgan Stanley, an estimated $3.56M added.
- The largest BIOTIE THERAPIES CORP SPONSORED ADR seller in Q1 2016 was Fidelity Investments, an estimated $15.2M sold.
Based on aggregated 13F filings for Q1 2016.